Tert-Butyl2-Oxo-4-(Tosyloxy)-2,5-Dihydro-1H-Pyrrole-1-Carboxylate

If the Tosyl Group Is Displaced Under Buchwald Conditions, What Halts Scale-Up?

Direct amination of the 4-position through palladium-catalyzed C–N coupling converts the tosylate ester into a versatile 4-amino-2,5-dihydro-1H-pyrrole intermediate that serves as a regiospecific entry to highly substituted pyrrolidine pharmacophores. The transformation exploits the electron-deficient character of the α,β-unsaturated lactam, rendering the tosylate a competent oxidative addition partner for Pd(0) species while suppressing β-hydride elimination. A formulation derived from production campaigns at 100–500 L scale pairs tris(dibenzylideneacetone)dipalladium(0) (Pd₂(dba)₃, 1–2 mol%) with 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (Xantphos, 2–4 mol%) in anhydrous 1,4-dioxane. Benzophenone imine or a primary alkyl/aryl amine (1.2 equiv) is introduced as the nucleophile, and powdered cesium carbonate (1.5 equiv) maintains a homogeneous reaction mixture at 85–95°C for 14–20 hours. Process analytical technology (PAT) monitoring of off-gas CO₂ evolution—released from partial decarboxylation of the Boc group under strongly basic, high-temperature conditions—has proven critical: a rise in free pyrrolinone impurity above 2.5 area% correlates with premature catalyst deactivation and a steep drop in turnover number. On a 200-kg input campaign, batch-to-batch variability in residual palladium was traced to moisture ingress in the cesium carbonate storage vessel, which promoted hydrolysis of the active catalyst species. Post-reaction work-up involves filtration through a Celite pad followed by a 5 wt% L-cysteine-functionalized silica gel plug (particle size 40–63 µm, ℓ/D 3:1) to achieve a palladium content below 10 µg/g. The isolated 4-aminopyrrolinone is then telescoped without intermediate drying into a Boc deprotection step employing 4 M HCl in 1,4-dioxane at 0–5°C, yielding the hydrochloride salt of a 4-aminopyrrolidin-2-one scaffold. This intermediate has been incorporated into dipeptidyl peptidase-4 (DPP-4) inhibitor analogs and certain hepatitis C NS5A replication complex inhibitors. Compliance with ICH Q3D Elemental Impurities Guideline requires an inductively coupled plasma mass spectrometry (ICP-MS) method with a limit of quantitation of 0.1 µg/g for Pd, and the final crystallized salt must also satisfy residual solvent limits for 1,4-dioxane (≤380 ppm, ICH Q3C Class 2) by headspace gas chromatography according to USP <467> Procedure A.

Manufacturing-Scale Suzuki Couplings on a 3-Pyrrolin-2-One Scaffold

Introduction of an aryl substituent at the 4-position of the 2-oxo-2,5-dihydro-1H-pyrrole core via a Suzuki-Miyaura cross-coupling has been validated across multiple 200-kg active pharmaceutical ingredient precursor campaigns. The tosylate serves as a pseudohalide, undergoes oxidative addition with tetrakis(triphenylphosphine)palladium(0) (Pd(PPh₃)₄, 2–3 mol%) in a degassed toluene/water biphasic system (5:1 v/v) containing 2.0 M aqueous sodium carbonate (1.8 equiv) and the appropriate arylboronic acid (1.05 equiv). The mixture is refluxed under nitrogen (≥99.999% purity) for 5–7 hours with a pitched-blade turbine agitator operating at a tip speed of 3.2 m/s, a mechanical parameter found necessary to overcome the initially poor interfacial contact that otherwise leaves 8–12% unreacted tosylate. Unlike the corresponding 4-bromo analogue, the tosylate electrophile suppresses competing protodeboronation because the liberated p-toluenesulfinate anion acts as a weakly basic sink that moderates the aqueous phase pH below 9.2, thereby preserving the acid-labile Boc carbamate. Following phase separation at 55°C, the organic layer is washed with 5% w/w NaCl solution and concentrated under reduced pressure (50 mbar, 45°C). Crystallization is induced by adding n-heptane (3 volumes) at 0–5°C with a linear cooling rate of 0.3°C/min to yield the 4-aryl-3-pyrrolin-2-one as an off-white solid with a purity exceeding 99.0 area% by HPLC-UV at 254 nm. Single-impurity thresholds of ≤0.15% are mandated for the homocoupling biaryl side product and the des-tosyl hydrolysis impurity. The final intermediate has progressed to structural analogs of tropomyosin receptor kinase (TRK) inhibitors approved under accelerated assessment pathways. Genotoxic impurity control follows ICH M7 addendum principles: methyl p-toluenesulfonate, a potential impurity derived from the tosyl precursor, is monitored by a dedicated LC-MS/MS method with a reporting threshold of 1.5 µg/g. Residual toluene and n-heptane are simultaneously quantified by headspace GC-FID using USP <467> Procedure C, ensuring compliance with the 890 ppm and 5000 ppm concentration limits for Class 2 and Class 3 solvents, respectively.

Residence time distribution in a tubular microreactor eliminates the hot-spot issues that plague the batch amination of the tosyloxy substrate. When a 0.25 M solution of the pyrrolinone and 1.5 equivalents of a secondary amine—commonly morpholine, N-Boc-piperazine, or thiomorpholine—in anhydrous acetonitrile is processed through a perfluoroalkoxy (PFA) coil (ID 1.0 mm, length 12 m) at 120°C under 15 bar back-pressure, the SN2-like displacement reaches >98% conversion within 12 minutes residence. This flow protocol entirely circumvents the thermal Boc fragmentation that begins at ≥105°C in a batch vessel, because the heat-transfer coefficient in the microchannel exceeds 2000 W/m²·K and the time-temperature integral is strictly controlled. The crude stream is quenched in-line with 0.5 M citric acid and extracted with 2-methyltetrahydrofuran, after which the organic phase flows through a packed-bed cartridge of MP-TMT palladium scavenger resin to reduce leached metal from upstream catalyst traces to <5 µg/g. The isolated 4-amino-3-pyrrolin-2-one products serve as late-stage diversification intermediates for DNA-encoded chemical library technology, where water content must remain below 200 ppm and single-isomer purity above 95% to prevent false-positive barcode events. Analytical release employs qNMR with 1,3,5-trimethoxybenzene as internal standard and ion chromatography for chloride rejection of amine hydrohalide precursors, in accordance with IUPAC harmonized guidelines for small-molecule library qualification.

Residual Palladium Below 10 ppm Is Non-Negotiable in a 3-Pyrrolinone SDHI Intermediate

Application of the 3-pyrrolinone tosylate in agricultural chemistry hinges on a cost-driven Suzuki protocol that must simultaneously satisfy a residual palladium ceiling of 10 µg/g in the isolated intermediate. Succinate dehydrogenase inhibitor (SDHI) fungicide candidates, derived from 4-(hetero)aryl-2-oxopyrrolidine motifs, rely on a catalytic system formed in situ from palladium(II) acetate (Pd(OAc)₂, 0.5 mol%) and triphenylphosphine (P:Pd ratio 4:1) in a 1,2-dimethoxyethane/water mixture (4:1 v/v) with potassium phosphate tribasic (2.0 equiv). The arylboronic acid (1.03 equiv) is added portion-wise over 1 hour at 75°C to maintain a low steady-state concentration of free boronic acid and minimize protodeboronation of electron-deficient coupling partners. Upon complete conversion, the batch is cooled to 50°C and treated with a 10% w/v aqueous solution of N-acetylcysteine (3 equiv relative to Pd) and stirred vigorously for 2 hours, then filtered through a 0.5 µm carbon block cartridge. The chelated palladium is further precipitated by adding sodium dimethyldithiocarbamate (20 ppm w/w) at 60°C during the solvent-exchange distillation from dimethoxyethane to methanol. For a 350-kg campaign, the optimized sequence delivered a crystalline intermediate with mean palladium content of 6.8 µg/g and total heavy metals (as Pb) below 20 µg/g as specified by FAO Specification 358/TC for technical-grade active ingredients. Purity analysis by HPLC on a C18 column (150 mm × 4.6 mm, 5 µm) under gradient elution must report no individual unknown impurity exceeding 0.10 area%. A key process bottleneck is the occlusion of sodium p-toluenesulfinate in the crystal lattice during the final methanol-water precipitation; inline attenuated total reflectance (ATR)-FTIR monitoring of the 1040 cm⁻¹ sulfinate band is used to trigger the precise cooling arrest point, ensuring the rinse cake contains <0.2% w/w sulfinate salt. The downstream fungicidal candidate is subjected to OECD 301B ready biodegradability screening before field trial batch registration.

A fully protected 2-oxopyrrolidine amino acid surrogate is accessed when the tosylate is displaced by a thioacetate nucleophile under strictly anhydrous conditions. Potassium thioacetate (1.8 equiv) is suspended in dry N,N-dimethylacetamide (DMAc, water content <100 ppm by Karl Fischer) and the pyrrolinone tosylate is added portion-wise at -10°C; the mixture is stirred for 4 hours and then allowed to warm to 10°C over 2 hours. The low-temperature regime prevents premature Boc loss that a free thiolate would otherwise induce through a base-mediated E1cB elimination pathway across the C5–N bond. The resulting 4-(acetylthio)-3-pyrrolin-2-one intermediate is reduced with sodium borohydride in ethanol/THF at -20°C to saturate the 3,4-double bond without affecting the thioester, yielding a protected 4-thio-L-proline analog after sequential hydrolysis of the acetyl group and Boc removal. When the final chemical entity is intended as a proline mimetic for parenteral biologics, the intermediate must pass endotoxin testing per USP <85> (limit 0.05 EU/mg), and residual DMAc is held below 1090 ppm according to ICH Q3C Option 2 limits. Chromatography on a 10 µm diol stationary phase using isocratic ethyl acetate/hexane achieves separation of the diastereoisomers that arise from the subsequent C5 stereocenter, a step that has been transferred directly from preclinical milligram-scale synthesis without re-optimization of the mobile phase hydric balance, providing a 3.2-minute resolution window between the (R) and (S) enantiomers as confirmed by chiral HPLC with a Chiralpak AD-H column.

A Question of Residual Solvent Class: How Does DMF Entrainment Affect a GMP Intermediate Used in Oncology?

The target oncology intermediate—a key building block for a B-cell lymphoma 2 (BCL-2) homology 3 (BH3) mimetic—retains 800–1200 ppm of N,N-dimethylformamide after aqueous work-up, prompting a dedicated solvent swap protocol. In the final coupling step, the tosylate group is displaced by a cyanoacetate enolate in DMF at 0°C, generating a 4-substituted pyrrolinone that bears both the Boc carbamate and a labile ethyl ester. Aqueous quench with ammonium chloride solution removes DMF poorly because the amide solvent co-extracts with the product into ethyl acetate and is only marginally stripped during concentration under 40 mbar at 40°C. The residual quantity is far in excess of the 880 ppm permitted by ICH Q3C (Class 2, PDE 8.8 mg/day). Introduction of a two-stage solvent displacement—first concentrating the ethyl acetate solution to 3 volumes, diluting with isopropyl alcohol (6 volumes), and re-concentrating at 85 mbar to reduce dimethylformamide content to 210 ppm, then repeating the cycle with fresh isopropyl alcohol—lowers the final level to 87 ppm as determined by headspace sampling of a 100 mg/mL solution in dimethylsulfoxide on a DB-624 capillary column (30 m × 0.53 mm, 3 µm) with FID detection at 250°C. The solid is further dried in a vacuum oven at 45°C and 500 Pa for 16 hours with a nitrogen bleed, meeting the threshold for pharmaceutical grade without changing the crystalline form as verified by XRPD. A typical solvent retention profile observed across 12 consecutive batches is compiled below for quality assurance benchmarking.

The BCL-2 intermediate must also undergo a dedicated Ames test evaluation (OECD 471) for the potential presence of ethyl p-toluenesulfonate, a mutagenic impurity classified under ICH M7 Class 3. Liquid chromatography-tandem mass spectrometry operating in multiple reaction monitoring mode with a Zorbax Eclipse Plus C18 column achieves a detection limit of 0.25 µg/g. Production batches are released only when ethyl tosylate content is below the threshold of toxicological concern (1.5 µg/day intake, corresponding to 7.5 µg/g at the maximum daily dose of the subsequent API). Any deviation in the solvent quality of the isopropyl alcohol used for displacement—especially the peroxide value exceeding 0.5 meq/L—has been correlated with oxidative degradation of the pyrrolinone ring and a rise in an unidentified late-eluting impurity at relative retention time 1.63. Therefore, the protocol specifies use of isopropyl alcohol that passes a potassium iodide-starch test limit of 0.3 meq/L prior to the solvent swap.